| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |